Search Results - "Poller, Birk"

Refine Results
  1. 1

    Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data by Kunze, Annett, Huwyler, Jörg, Camenisch, Gian, Poller, Birk

    Published in Drug metabolism and disposition (01-09-2014)
    “…Organic anion-transporting polypeptides (OATP) 1B1 and OATP1B3 are drug transporters mediating the active hepatic uptake of their substrates. Because they…”
    Get full text
    Journal Article
  2. 2

    A Systematic In Vitro Investigation of the Inhibitor Preincubation Effect on Multiple Classes of Clinically Relevant Transporters by Tátrai, Péter, Schweigler, Patrick, Poller, Birk, Domange, Norbert, de Wilde, Roelof, Hanna, Imad, Gáborik, Zsuzsanna, Huth, Felix

    Published in Drug metabolism and disposition (01-07-2019)
    “…Preincubation of a drug transporter with its inhibitor in a cell-based assay may result in the apparent enhancement of the inhibitory potency. Currently,…”
    Get full text
    Journal Article
  3. 3

    human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies by Poller, Birk, Gutmann, Heike, Krähenbühl, Stephan, Weksler, Babette, Romero, Ignacio, Couraud, Pierre-Olivier, Tuffin, Gerald, Drewe, Jürgen, Huwyler, Jörg

    Published in Journal of neurochemistry (01-12-2008)
    “…The human brain endothelial capillary cell line hCMEC/D3 has been developed recently as a model for the human blood-brain barrier. In this study a further…”
    Get full text
    Journal Article
  4. 4

    The application of organ-on-chip models for the prediction of human pharmacokinetic profiles during drug development by Keuper-Navis, Marit, Walles, Markus, Poller, Birk, Myszczyszyn, Adam, van der Made, Thomas K., Donkers, Joanne, Eslami Amirabadi, Hossein, Wilmer, Martijn J., Aan, Saskia, Spee, Bart, Masereeuw, Rosalinde, van de Steeg, Evita

    Published in Pharmacological research (01-09-2023)
    “…Organ-on-chip (OoC) technology has led to in vitro models with many new possibilities compared to conventional in vitro and in vivo models. In this review, the…”
    Get full text
    Journal Article
  5. 5

    Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood-Brain Barrier by Poller, Birk, Drewe, Jürgen, Krähenbühl, Stephan, Huwyler, Jörg, Gutmann, Heike

    Published in Cellular and molecular neurobiology (01-01-2010)
    “…Brain capillary endothelial cells form the blood-brain barrier (BBB), a highly selective permeability membrane between the blood and the brain. Besides tight…”
    Get full text
    Journal Article
  6. 6

    In vitro-in vivo extrapolation method to predict human renal clearance of drugs by Kunze, Annett, Huwyler, Jörg, Poller, Birk, Gutmann, Heike, Camenisch, Gian

    Published in Journal of pharmaceutical sciences (01-03-2014)
    “…Renal clearance is a key determinant of the elimination of drugs. To date, only few in vitro-in vivo extrapolation (IVIVE) approaches have been described to…”
    Get more information
    Journal Article
  7. 7

    New IVIVE method for the prediction of total human clearance and relative elimination pathway contributions from in vitro hepatocyte and microsome data by Riede, Julia, Poller, Birk, Umehara, Ken-ichi, Huwyler, Jörg, Camenisch, Gian

    “…Total human clearance is a key determinant for the pharmacokinetic behavior of drug candidates. Our group recently introduced the Extended Clearance Model…”
    Get full text
    Journal Article
  8. 8

    Double-Transduced MDCKII Cells To Study Human P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Interplay in Drug Transport across the Blood−Brain Barrier by Poller, Birk, Wagenaar, Els, Tang, Seng Chuan, Schinkel, Alfred H

    Published in Molecular pharmaceutics (04-04-2011)
    “…P-glycoprotein (P-gp/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) combination knockout mice display disproportionately increased brain penetration…”
    Get full text
    Journal Article
  9. 9

    Novel Bruton’s Tyrosine Kinase inhibitor remibrutinib: Drug‐drug interaction potential as a victim of CYP3A4 inhibitors based on clinical data and PBPK modeling by Huth, Felix, Schiller, Hilmar, Jin, Yi, Poller, Birk, Schuhler, Carole, Weis, Wendy, Woessner, Ralph, Drollmann, Anton, End, Peter

    Published in Clinical and translational science (01-01-2022)
    “…Remibrutinib, a novel oral Bruton’s Tyrosine Kinase inhibitor (BTKi) is highly selective for BTK, potentially mitigating the side effects of other BTKis…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Differential Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on Axitinib Brain Accumulation and Oral Plasma Pharmacokinetics by POLLER, Birk, IUSUF, Dilek, SPARIDANS, Rolf W, WAGENAAR, Els, BEIJNEN, Jos H, SCHINKEL, Alfred H

    Published in Drug metabolism and disposition (01-05-2011)
    “…The second-generation tyrosine kinase inhibitor and anticancer drug axitinib is a potent, orally active inhibitor of the vascular endothelial growth factor…”
    Get full text
    Journal Article
  12. 12

    Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3 by Fasler-Kan, Elizaveta, Suenderhauf, Claudia, Barteneva, Natasha, Poller, Birk, Gygax, Daniel, Huwyler, Jörg

    Published in Brain research (01-10-2010)
    “…Abstract Brain microvascular endothelial cells are part of the blood–brain barrier and participate actively in immunological processes including…”
    Get full text
    Journal Article
  13. 13

    Simplifying the Extended Clearance Concept Classification System (EC3S) to Guide Clearance Prediction in Drug Discovery by Patel, Mitesh, Riede, Julia, Bednarczyk, Dallas, Poller, Birk, Deshmukh, Sujal V.

    Published in Pharmaceutical research (01-04-2023)
    “…Purpose The Extended Clearance Concept Classification System was established as a development-stage tool to provide a framework for identifying fundamental…”
    Get full text
    Journal Article
  14. 14

    Improving In Vitro-In Vivo Extrapolation (IVIVE) of Clearance Using Rat Liver Microsomes for Highly Plasma Protein Bound Molecules by Trunzer, Markus, Teigão, Joana, Huth, Felix, Poller, Birk, Desrayaud, Sandrine, Rodríguez-Pérez, Raquel, Faller, Bernard

    Published in Drug metabolism and disposition (01-05-2024)
    “…It is common practice in drug discovery and development to predict in vivo hepatic clearance from in vitro incubations with liver microsomes or hepatocytes…”
    Get full text
    Journal Article
  15. 15

    Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic Concentrations by Riede, Julia, Poller, Birk, Huwyler, Jörg, Camenisch, Gian

    Published in Drug metabolism and disposition (01-05-2017)
    “…Inhibition of the bile salt export pump (BSEP) has been recognized as a key factor in the development of drug-induced cholestasis (DIC). The risk of DIC in…”
    Get full text
    Journal Article
  16. 16

    Clinical Investigation of Metabolic and Renal Clearance Pathways Contributing to the Elimination of Fevipiprant Using Probenecid as Perpetrator by Weiss, H Markus, Langenickel, Thomas, Cain, Meredith, Kulkarni, Swarupa, Shah, Bharti, Vemula, Janardhana, Rahmanzadeh, Gholamreza, Poller, Birk

    Published in Drug metabolism and disposition (01-05-2021)
    “…Fevipiprant, an oral, nonsteroidal, highly selective, reversible, and competitive prostaglandin D receptor 2 antagonist, is eliminated by glucuronidation and…”
    Get full text
    Journal Article
  17. 17

    Drug-induced cholestasis (DIC) predictions based on in vitro inhibition of major bile acid clearance mechanisms by Kastrinou-Lampou, Vlasia, Rodríguez-Pérez, Raquel, Poller, Birk, Huth, Felix, Schadt, Heiko S., Kullak-Ublick, Gerd A., Arand, Michael, Camenisch, Gian

    Published in Archives of toxicology (14-11-2024)
    “…Drug-induced cholestasis (DIC) is recognized as a major safety concern in drug development, as it represents one of the three types of drug-induced liver…”
    Get full text
    Journal Article
  18. 18

    Absorption, Distribution, Metabolism, and Excretion of [ 14 C]iptacopan in Healthy Male Volunteers and in In Vivo and In Vitro Studies by James, Alexander David, Kulmatycki, Kenneth, Poller, Birk, Romeo, Andrea A, Van Lier, Jan Jaap, Klein, Kai, Pearson, David

    Published in Drug metabolism and disposition (01-07-2023)
    “…Iptacopan (LNP023) is an oral, small-molecule, first-in-class, highly potent proximal complement inhibitor that specifically binds factor B and inhibits the…”
    Get full text
    Journal Article
  19. 19

    The extended clearance model and its use for the interpretation of hepatobiliary elimination data by Camenisch, Gian, Riede, Julia, Kunze, Annett, Huwyler, Jörg, Poller, Birk, Umehara, Kenichi

    Published in ADMET & DMPK (31-03-2015)
    “…Hepatic elimination is a function of the interplay between different processes such as sinusoidal uptake, intracellular metabolism, canalicular (biliary)…”
    Get full text
    Journal Article
  20. 20

    Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes by Kastrinou Lampou, Vlasia, Poller, Birk, Huth, Felix, Fischer, Audrey, Kullak-Ublick, Gerd A., Arand, Michael, Schadt, Heiko S., Camenisch, Gian

    Published in Toxicology in vitro (01-03-2023)
    “…Bile acid (BA) homeostasis is a complex and precisely regulated process to prevent impaired BA flow and the development of cholestasis. Several reactions,…”
    Get full text
    Journal Article